Literature DB >> 13108974

The effects of antimicrobial agents upon choline degradation in the intestinal tract.

J DE LA HUERGA, P GYORGY, S WALDSTEIN, R KATZ, H POPPER.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/effects; CHOLINE/metabolism; INTESTINES/metabolism

Mesh：

Substances：

Year:  1953        PMID： 13108974      PMCID： PMC438450          DOI： 10.1172/JCI102835

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Antimicrobial agents in the prevention of experimental dietary injury of the liver.

Authors:  P GYORGY; J STOKES; H GOLDBLATT
Journal:  Trans Assoc Am Physicians       Date:  1951

2.  Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases.

Authors:  J de la HUERGA; H POPPER
Journal:  J Clin Invest       Date:  1951-05       Impact factor: 14.808

3.  The excretion and concentration of aureomycin in the abnormal human biliary tract.

Authors:  J ZASLOW; T H HEWLETT; R GOLDSMITH
Journal:  Gastroenterology       Date:  1950-10       Impact factor: 22.682

4.  The excretion and concentration of aureomycin in the abnormal human biliary tract.

Authors:  J ZASLOW; T H HEWLETT; R W LORRY
Journal:  Gastroenterology       Date:  1950-10       Impact factor: 22.682

5.  Cortisone, ACTH and antibiotics in fulminant hepatitis.

Authors:  H DUCCI; R KATZ
Journal:  Gastroenterology       Date:  1952-07       Impact factor: 22.682

6.  Factors influencing choline absorption in the intestinal tract.

Authors:  J DE LA HUERGA; H POPPER
Journal:  J Clin Invest       Date:  1952-06       Impact factor: 14.808

7.  Effects of aureomycin on renal lesions, liver lipid, and tissue choline in choline deficiency.

Authors:  J H BAXTER; H CAMPBELL
Journal:  Proc Soc Exp Biol Med       Date:  1952-07

8.  Studies on the use of aureomycin in hepatic disease. III. A note on aureomycin therapy in hepatic coma.

Authors:  J D FARQUHAR; J STOKES; C M WHITLOCK; L W BLUEMLE; J M GAMBESCIA
Journal:  Am J Med Sci       Date:  1950-08       Impact factor: 2.378

9.  Antimicrobial agents in the prevention of dietary hepatic injury (necrosis, cirrhosis) in rats.

Authors:  P GYORGY; J STOKES; H GOLDBLATT; H POPPER
Journal:  J Exp Med       Date:  1951-06       Impact factor: 14.307
  9 in total
  2 in total

1.  Importance of choline during growth, with particular reference to synthetic diets in phenylketonuria.

Authors:  K M WILSON; B E CLAYTON
Journal:  Arch Dis Child       Date:  1962-12       Impact factor: 3.791

2.  Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.

Authors:  Lesley Hoyles; Maria L Jiménez-Pranteda; Julien Chilloux; Francois Brial; Antonis Myridakis; Thomas Aranias; Christophe Magnan; Glenn R Gibson; Jeremy D Sanderson; Jeremy K Nicholson; Dominique Gauguier; Anne L McCartney; Marc-Emmanuel Dumas
Journal:  Microbiome       Date:  2018-04-20       Impact factor: 14.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.